FDA DEVICE FACTS
BIOFIRE FILMARRAY Tropical Fever Panel
Biofire Diagnostics, LLC (Biomerieux)
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel is an automated, qualitative, multiplexed polymerase chain reaction (PCR) test intended for use with BIOFIRE® FILMARRAY® 2.0 and BIOFIRE® FILMARRAY® TORCH Systems. The BIOFIRE FILMARRAY TF Panel detects and identifies selected bacterial, viral, and parasitic nucleic acids directly from EDTA whole blood collected from individuals with signs and/or symptoms of acute febrile illness or recent acute febrile illness and known or suspected exposure to the following target pathogens: chikungunya virus, dengue virus (serotypes 1, 2, 3 and 4), Leptospira spp., and Plasmodium spp. (including species differentiation of Plasmodium falciparum and Plasmodium vivax/ovale).
Evaluation for more common causes of acute febrile illness (e.g., infections of the upper and lower respiratory tract or gastroenteritis, as well as non-infectious causes) should be considered prior to evaluation with this panel. Results are meant to be used in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the relevant public health authorities.
The BIOFIRE FILMARRAY TF Panel is not intended to be used as the sole basis for diagnosis, treatment, or other management decisions. Positive results do not rule out co-infection with other organisms not included on the BIOFIRE FILMARRAY TF Panel, nor do negative results rule out infection. Negative results from the BIOFIRE FILMARRAY TF Panel may require additional testing if clinically indicated. Not all pathogens that cause acute febrile illness are detected by this test, and negative results do not rule out the presence of other infections.
In the United States, patient travel history, exposure risk, and consultation of the CDC Yellow Book should be considered prior to use of the BIOFIRE FILMARRAY TF Panel as some pathogens are more common in certain geographical locations. The BioFire ® Global Fever Panel is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with BioFire® FilmArray® 2.0 and BioFire® FilmArray® Torch Systems. The BioFire Global Fever Panel detects and identifies selected bacterial, viral, and protozoan nucleic acids directly from EDTA whole blood collected from individuals with signs and/or symptoms of acute febrile illness or recent acute febrile illness and known or suspected exposure to the following target pathogens: chikungunya virus, dengue virus (serotypes 1, 2, 3 and 4), Leptospira spp., and Plasmodium spp. (including species differentiation of Plasmodium falciparum and Plasmodium vivax/ovale). Evaluation for more common causes of acute febrile illness (e.g., infections of the upper and lower respiratory tract or gastroenteritis, as well as non-infectious causes) should be considered prior to evaluation with this panel. Results are meant to be used in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the relevant public health authorities.
Positive results do not rule out co-infections with pathogens not included on the BioFire Global Fever Panel. Not all pathogens that cause acute febrile illness are detected by this test, and negative results do not rule out the presence of other infections. In the United States, patient travel history and consultation of the CDC Yellow Book should be considered prior to use of the BioFire Global Fever Panel as some pathogens are more common in certain geographical locations. Organisms Detected Leptospira spp. Chikungunya virus Dengue virus (serotypes 1, 2, 3 and 4) Plasmodium spp. Plasmodium falciparum Plasmodium vivax/ovale Same Analyte DNA/RNA Same Specimen Types Whole blood (collected in EDTA tube) Same Technological Principles Nested multiplex PCR followed by high resolution melting analysis to confirm the identity of amplified product. Same Instrumentation BIOFIRE 2.0 System or BIOFIRE TORCH System Same Time to result ~ 50 minutes Same Test Interpretation Automated test interpretation and report generation. User cannot access raw data. Same Sample Preparation Method Sample Processing is automated in the BIOFIRE System. Same Reagent Storage Reagents are stored at room temperature. Same Shelf-Life 12 months from Date of Manufacture. Same BIOFIRE® FILMARRAY® Tropical Fever Panel November 07, 2024 Page 5 Element Modified Device: BIOFIRE FILMARRAY TF Panel Predicate: BioFire Global Fever Panel (K220870)
Controls Two controls are included in each reagent pouch to control for sample processing and both stages of PCR and melt analysis. Same User Complexity Moderate Same Legal Manufacturer *BioFire Diagnostics, LLC. *BioFire Defense, LLC. *Note: BioFire Diagnostics, LLC and BioFire Defense, LLC are both wholly owned subsidiaries of bioMérieux, Inc.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。